Sun 12 Oct 2008 | 20:15 EDT
You are here: Home > News > Article
Home
Business & Finance
News
U.S.
Politics
International
Technology
Entertainment
Sports
Lifestyle
Oddly Enough
Environment
Health
Science
Special Coverage
Video
Pictures
You Witness
Blogs
Reader Feedback
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
You Witness News
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Teva Pharm announces approval of Alprazolam E.R. Tablets

Thu Mar 1, 2007 6:22am EST
 
Email | Print | | Reprints | Single Page
[-] Text [+]
Co announces that the FDA has granted approval for the co's Abbreviated New Drug Application for Alprazolam Extended Release Tablets, 0.5 mg, 1 mg, 2 mg and 3 mg. Total annual sales of this product, including brand and generic sales, are approximately $54 million, based on IMS sales data.

 

also on reuters

Featured Broker sponsored link

Editor's Choice

  • Pictures
  • Video
  • Articles
Photo

A selection of our best photos from the past 24 hours.  View Slideshow 

Most Popular on Reuters

  • Articles
  • Video
  • Recommended

Reuters Oddly Enough

Funny, quirky, strange-but-true stories from around the world.
Photo
Watch the videos
Read the stories
Get the daily newsletter
Check out the blog